J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

NSE:JBCHEPHARM Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	1,151	882.15	769.34	565.44	286.86
Short-Term Investments	178.92	67.7	0.85	1.06	-
Trading Asset Securities	3,171	3,647	1,922	-	6,650
Cash & Short-Term Investments	4,501	4,596	2,692	566.5	6,937
Cash Growth	-2.08%	70.74%	375.20%	-91.83%	91.19%
Accounts Receivable	8,154	6,869	5,758	5,557	3,890
Other Receivables	95.76	160.06	275.92	411.27	290.23
Receivables	8,255	7,036	6,048	5,981	4,185
Inventory	5,290	5,025	4,305	4,100	3,474
Prepaid Expenses	190.14	163.23	167.05	120.4	122.56
Other Current Assets	991.77	1,713	2,069	1,764	807.15
Total Current Assets	19,227	18,533	15,280	12,532	15,526
Property, Plant & Equipment	6,566	6,349	5,764	5,668	5,697
Long-Term Investments	2,784	285.13	137.84	127.22	129.09
Goodwill	574.59	574.59	574.59	574.59	574.59
Other Intangible Assets	13,171	13,885	13,223	6,714	321.05
Long-Term Deferred Tax Assets	84.19	58.78	65.1	64.31	69.43
Other Long-Term Assets	326.35	250.14	486.97	386.74	58.93
Total Assets	42,738	39,941	35,539	26,074	22,381
Accounts Payable	4,107	3,563	2,386	2,245	1,869
Accrued Expenses	202.33	167.83	176.15	247.43	241.37
Short-Term Debt	138.04	153.43	280.18	263.15	326.45
Current Portion of Long-Term Debt	-	3,182	1,370	-	-
Current Portion of Leases	77.33	108.77	88.87	76.26	72.02
Current Income Taxes Payable	82.3	117.62	49.54	60.95	79.02
Current Unearned Revenue	10.84	12.19	11.83	17.06	16.6
Other Current Liabilities	1,705	1,378	1,181	927.51	848.05
Total Current Liabilities	6,323	8,682	5,544	3,837	3,453
Long-Term Debt	-	236.39	3,832	-	-
Long-Term Leases	63.53	96.38	153.21	206.18	51.41
Long-Term Unearned Revenue	19.01	16.99	24.93	31.66	49.32
Long-Term Deferred Tax Liabilities	1,773	1,492	1,028	475.59	567.67
Other Long-Term Liabilities	221.9	183.26	146.1	132.19	112.09
Total Liabilities	8,405	10,708	10,735	4,688	4,247
Common Stock	155.68	155.2	154.76	154.56	154.56
Additional Paid-In Capital	1,641	1,134	697.02	507.68	507.68
Retained Earnings	30,857	26,676	22,757	19,933	17,354
Comprehensive Income & Other	1,679	1,268	1,195	745.66	80.81
Total Common Equity	34,333	29,233	24,804	21,341	18,097
Minority Interest	-	-	-	44.9	37.05
Shareholders' Equity	34,333	29,233	24,804	21,386	18,134
Total Liabilities & Equity	42,738	39,941	35,539	26,074	22,381
Total Debt	278.9	3,777	5,724	545.59	449.88
Net Cash (Debt)	4,222	819.79	-3,032	20.92	6,487
Net Cash Growth	415.01%	-	-	-99.68%	98.28%
Net Cash Per Share	26.61	5.17	-19.36	0.14	41.97
Filing Date Shares Outstanding	155.68	155.19	154.76	154.56	154.56
Total Common Shares Outstanding	155.68	155.19	154.76	154.56	154.56
Working Capital	12,904	9,851	9,736	8,694	12,073
Book Value Per Share	220.54	188.37	160.28	138.07	117.09
Tangible Book Value	20,587	14,774	11,006	14,053	17,202
Tangible Book Value Per Share	132.24	95.20	71.12	90.92	111.29
Land	329.41	329.41	5.72	5.72	5.72
Buildings	3,234	3,111	2,925	2,833	2,696
Machinery	9,697	8,767	8,363	8,095	7,800
Construction In Progress	467	633.22	444.09	139.06	255.67

Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.